"As a premier retina practice in the San Fernando Valley, The Retina Partners provide the full spectrum of services in the Encino office. Our doctors have at their disposal the most advanced equipment including high definition optical coherence tomography (SD-OCT), argon laser for treatment of a multitude of retinal conditions, and photodynamic therapy laser (PDT) for the treatment of macular degeneration (AMD) and central serous retinopathy. The Encino office also serves as the headquarters for our clinical trials."

During the past decade, The Retina Partners conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 9 clinical trials were completed, i.e. on average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 9 clinical trials were completed. i.e. 52.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Retina Partners" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Genentech, Inc." with 7 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Allergan" with 1 trials sponsored and "Graybug Vision" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Retina Partners" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Retina Partners" are "Geographic Atrophy" (8 trials), "Diabetic Macular Edema" (4 trials), "Macular Degeneration" (3 trials), "Neovascular Age-Related Macular Degeneration" (3 trials) and "Macular Degeneration, Age-Related" (2 trials). Many other conditions were trialed in "The Retina Partners" in a lesser frequency.

Most popular intervention types in "The Retina Partners" are "Drug" (24 trials), "Other" (8 trials), "Procedure" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Faricimab" (8 trials), "Aflibercept" (5 trials), "Ranibizumab" (4 trials) and "Galegenimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Retina Partners" are 27 trials for "All" genders.

Currently, there are NaN active trials in "The Retina Partners". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in The Retina Partners, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Retina Partners, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".